rxstat › Classes › Other Urologicals, Incl Antispasmodics
Other Urologicals, Incl Antispasmodics: shortage status in Canada
10 of the 14 other urologicals, incl antispasmodics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageAlprostadil3 of 5 reported products affectedWidespread shortageFlavoxate2 of 2 reported products affectedWidespread shortageTolterodine8 of 16 reported products affected · est. return Sep 8, 2026Partial shortageDarifenacin1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageFesoterodine1 of 4 reported products affected · est. return Jan 29, 2027Partial shortageOxybutynin Chloride2 of 11 reported products affectedPartial shortagePhenazopyridine1 of 2 reported products affectedPartial shortageSolifenacin7 of 25 reported products affected · est. return Jul 24, 2026Partial shortageTadalafil2 of 45 reported products affected · est. return Jun 19, 2026Partial shortageTrospium Chloride1 of 2 reported products affected · est. return Dec 31, 2026No current shortageDimethyl SulfoxideDiscontinuedOxybutynin0 of 1 reported products affectedNo current shortageVardenafilDiscontinuedYohimbine0 of 3 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.